Skip to content

Liraglutide clinical trials: 262 trials

Page 3 of 6

  1. Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

    NCT00331851 · Phase 3 · Completed

    Linked paper with results

  2. Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

    NCT00333151 · Phase 3 · Completed

    Linked paper with results

  3. Improving Beta Cell Function in Mexican American Women With Prediabetes

    NCT02488057 · Phase 4 · Completed

    Linked paper with results

  4. Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes

    NCT03421119 · Phase 3 · Status unknown

    Linked paper with results

  5. Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet

    NCT04122716 · Phase 4 · Status unknown

    Linked paper with results

  6. Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility

    NCT05952882 · Phase 3 · Status unknown

    Linked paper with results

  7. Liraglutide 3 mg for Knee Osteoarthritis

    NCT02905864 · Phase 4 · Completed

    Linked paper with results

  8. Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism

    NCT02721888 · Phase 4 · Terminated

    Linked paper with results

  9. Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes

    NCT03449654 · Phase 4 · Completed

    Linked paper with results

  10. Liraglutide in Type 1 Diabetes

    NCT01612468 · Phase 4 · Completed

    Linked paper with results

  11. Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome

    NCT04575844 · Phase 4 · Recruiting

    Linked paper with results

  12. SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity

    NCT04775082 · Phase 3 · Active, not recruiting

    Linked paper with results

  13. Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response

    NCT03341429 · Phase 4 · Completed

    Linked paper with results

  14. Effect of Liraglutide on Microbiome in Obesity

    NCT04046822 · Phase 4 · Status unknown

    Linked paper with results

  15. SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies

    NCT01744236 · Phase 4 · Completed

    Linked paper with results

  16. Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue

    NCT05767255 · Phase 3 · Status unknown

    Linked paper with results

  17. LIraglutide and Beta-cell RepAir (LIBRA) Study

    NCT01270789 · Phase 3 · Completed

    Linked paper with results

  18. Liraglutide Effect in Atrial Fibrillation

    NCT03856632 · Phase 4 · Active, not recruiting

    Linked paper with results

  19. Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists

    NCT07325435 · Phase 4 · Active, not recruiting

    Linked paper with results

  20. The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function

    NCT02473809 · Phase 4 · Completed

    Linked paper with results

  21. Targeting Beta-cell Failure in Lean Patients With Type 2 Diabetes

    NCT04657939 · Phase 4 · Completed

    Linked paper with results

  22. Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent

    NCT02660047 · Phase 4 · Completed

    Linked paper with results

  23. Effect of GLP-1 on Angiogenesis

    NCT02686177 · Phase 4 · Completed

    Linked paper with results

  24. Preoperative Condition in Giant Obese Patients

    NCT02616003 · Phase 4 · Completed

    Linked paper with results

  25. Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients

    NCT01761318 · Phase 4 · Completed

    Linked paper with results

  26. PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome

    NCT02187250 · Phase 4 · Completed

    Linked paper with results

  27. The Lira Pump Trial

    NCT02351232 · Phase 2/3 · Completed

    Linked paper with results

  28. Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus

    NCT01208012 · Phase 4 · Completed

    Linked paper with results

  29. Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and Obese

    NCT01739049 · Phase 4 · Completed

    Linked paper with results

  30. The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes

    NCT01595789 · Phase 4 · Completed

    Linked paper with results

  31. LIROH - Liraglutide for Obesity in HIV

    NCT06438146 · Phase 4 · Status unknown

    Linked paper with results

  32. Effects of Liraglutide in Chronic Obstructive Pulmonary Disease

    NCT03466021 · Phase 4 · Completed

    Linked paper with results

  33. Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients

    NCT02655770 · Phase 4 · Completed

    Linked paper with results

  34. Liraglutide as add-on to Insulin in Type 1 Diabetes

    NCT02092896 · Phase 3 · Completed

    Linked paper with results

  35. Liraglutide Treatment to Patients With Severe Renal Insufficiency

    NCT01394341 · Phase 4 · Completed

    Linked paper with results

  36. Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults

    NCT02654665 · Phase 3 · Status unknown

    Linked paper with results

  37. Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin

    NCT01911468 · Phase 4 · Completed

    Linked paper with results

  38. Short Term Weight Loss With Liraglutide and Metformin in Infertile Obese PCOS Patients

    NCT03034941 · Phase 4 · Completed

    Linked paper with results

  39. Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis

    NCT02602600 · Phase 4 · Completed

    Linked paper with results

  40. Antiproteinuric Effects of Liraglutide Treatment

    NCT02545738 · Phase 4 · Completed

    Linked paper with results

  41. Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes

    NCT01499108 · Phase 4 · Completed

    Linked paper with results

  42. Use of Liraglutide in Children Aged 6 to 12 Years With Severe Obesity

    NCT07590219 · Phase 4 · Active, not recruiting

    Linked paper with results

  43. Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus

    NCT03707171 · Phase 3 · Completed

    Linked paper with results

  44. The Effect of a Liraglutide on IVF in Obese PCOS

    NCT03353948 · Phase 4 · Completed

    Linked paper with results

  45. Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity

    NCT02909933 · Phase 4 · Completed

    Linked paper with results

  46. Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes

    NCT00993720 · Phase 2/3 · Completed

    Linked paper with results

  47. Saxenda: Underlying Mechanisms and Clinical Outcomes

    NCT02944500 · Phase 4 · Active, not recruiting

    Linked paper with results

  48. Blood Pressure Outcomes With Liraglutide Therapy

    NCT01755572 · Phase 4 · Completed

    Linked paper with results

  49. Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.

    NCT01931982 · Phase 4 · Completed

    Linked paper with results

  50. The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)

    NCT01610934 · Phase 2/3 · Completed

    Linked paper with results

How PepBank reports evidence